Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Buy Us a Coffee
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2025-65754
Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Cross Site Scripting vulnerability in Algernon v1.17.4 allows attackers to execute arbitrary code via injecting a crafted payload into a filename.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
algernon 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
algernon是Alexander F. Rødseth个人开发者的一个 Web 服务器。 algernon 1.17.4版本存在安全漏洞，该漏洞源于文件名中存在跨站脚本，可能导致执行任意代码。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2025-65754
#POC DescriptionSource LinkShenlong Link
1Algernon v1.17.4 is affected by a Cross-Site Scripting (XSS) vulnerability that allows attackers to execute arbitrary code via a crafted payload into a filename.https://github.com/Bnyt7/CVE-2025-65754POC Details
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2025-65754
Please Login to view more intelligence information
IV. Related Vulnerabilities
Same product: n/a
Same vendor: n/a
V. Comments for CVE-2025-65754

No comments yet

Leave a comment